Product NDC: | 14789-300 |
Proprietary Name: | Benztropine Mesylate |
Non Proprietary Name: | BENZTROPINE MESYLATE |
Active Ingredient(s): | 1 mg/mL & nbsp; BENZTROPINE MESYLATE |
Administration Route(s): | PARENTERAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14789-300 |
Labeler Name: | Nexus Pharmaceuticals Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090233 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090729 |
Package NDC: | 14789-300-02 |
Package Description: | 5 VIAL in 1 PACKAGE (14789-300-02) > 2 mL in 1 VIAL |
NDC Code | 14789-300-02 |
Proprietary Name | Benztropine Mesylate |
Package Description | 5 VIAL in 1 PACKAGE (14789-300-02) > 2 mL in 1 VIAL |
Product NDC | 14789-300 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BENZTROPINE MESYLATE |
Dosage Form Name | INJECTION |
Route Name | PARENTERAL |
Start Marketing Date | 20090729 |
Marketing Category Name | ANDA |
Labeler Name | Nexus Pharmaceuticals Inc |
Substance Name | BENZTROPINE MESYLATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |